EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Geleophysic Dysplasia Associated With FBN1 Mutation: Clinical Course, Valvular Heart Disease, and Response to Recombinant Human Growth Hormone Therapy

Ray Thomas Katbe, Laure Boutsen, Philippe A. Lysy

Clinical Case Reports · 2026-04 · 14 (4)

DOI: 10.1002/ccr3.71957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 26.03.2026. Verfasst von Ray Thomas Katbe und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Geleophysic dysplasia (GD) is a rare genetic condition caused by pathogenic variants in either the ADAMTSL2 or FBN1 gene. We present a patient that combined clinical features consistent with GD, including short stature, delayed bone age, progressive congenital heart disease, and a happy, round face. Genetic analysis revealed a heterozygous missense pathogenic variant c.5284G>A (p.(Gly1762Ser)) in exon 42 of the FBN1 gene, previously reported as causative of GD. Given the condition's under‐recognition, this case report highlights key diagnostic features and the approach to differential diagnosis in a child with short stature, emphasizing the need for early identification. Furthermore, the use of recombinant human growth hormone (rhGH), initiated after evidence of a partial isolated growth hormone deficiency, did not lead to significant improvement, but its discontinuation was associated with worsening growth, which improved again after reintroduction. This paradoxical response raises important questions about rhGH use in GD and underlines the need for continued auxological and cardiac monitoring and individualized treatment strategies.

Zitieren

APA

Katbe, R. T., Boutsen, L., & Lysy, P. A. (2026). Geleophysic Dysplasia Associated With FBN1 Mutation: Clinical Course, Valvular Heart Disease, and Response to Recombinant Human Growth Hormone Therapy. Clinical Case Reports, 14(4). https://doi.org/10.1002/ccr3.71957

Vancouver

Katbe RT, Boutsen L, Lysy PA. Geleophysic Dysplasia Associated With FBN1 Mutation: Clinical Course, Valvular Heart Disease, and Response to Recombinant Human Growth Hormone Therapy. Clinical Case Reports. 2026;14(4). doi:10.1002/ccr3.71957

BibTeX
@article{Katbe2026,
  author = {Katbe, Ray Thomas and Boutsen, Laure and Lysy, Philippe A.},
  title = {Geleophysic Dysplasia Associated With FBN1 Mutation: Clinical Course, Valvular Heart Disease, and Response to Recombinant Human Growth Hormone Therapy},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/ccr3.71957}
}
Kostenlos starten →